TELESIS BIO INC (TBIO) Forecast, Price Target & Analyst Ratings

NASDAQ:TBIOUS1920032000

Current stock price

3.23 USD
-0.76 (-19.05%)
At close:
2.85 USD
-0.38 (-11.76%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TELESIS BIO INC (TBIO).

Forecast Snapshot

Consensus Price Target

Price Target
$4.08
+ 26.32% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 11, 2024
Period
Q4 / 2024
EPS Estimate
-$2.91
Revenue Estimate
9.18M

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.08
Upside
+ 26.32%
From current price of $3.23 to mean target of $4.08, Based on 7 analyst forecasts
Low
$4.04
Median
$4.08
High
$4.20

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for TBIO. The average price target is 4.08 USD. This implies a price increase of 26.32% is expected in the next year compared to the current price of 3.23.

Analyst Ratings & History

Current Analyst Ratings

TBIO Current Analyst RatingTBIO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

TBIO Historical Analyst RatingsTBIO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
TBIO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TBIO.
In the previous month the buy percentage consensus was at a similar level.
TBIO was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-08-11KeybancDowngrade Overweight -> Sector Weight
2021-08-04Roth CapitalMaintains Neutral
2021-08-03William BlairDowngrade Outperform -> Market Perform
2021-08-03SVB LeerinkMaintains Market Perform
2021-07-26Roth CapitalMaintains Buy
2021-05-10SVB LeerinkMaintains Market Perform
2021-03-23SVB LeerinkDowngrade Outperform -> Market Perform
2021-03-18SVB LeerinkMaintains Outperform
2021-03-18Evercore ISI GroupDowngrade Outperform -> In-Line
2021-03-18Roth CapitalMaintains Buy
2021-03-18Truist SecuritiesDowngrade Buy -> Hold
2021-03-18HC Wainwright & Co.Maintains Buy
2021-03-01SVB LeerinkMaintains Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 11, 2024
Period
Q4 / 2024
EPS Estimate
-$2.91
Revenue Estimate
9.18M
Revenue Q2Q
31.58%
EPS Q2Q
29.78%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-74.68%
EPS (1 Month)
0.00%
EPS (3 Months)
-101.22%

Next Earnings Summary

TBIO is expected to report earnings on 11/11/2024. The consensus EPS estimate for the next earnings is -2.91 USD and the consensus revenue estimate is 9.18M USD.
The next earnings revenue estimate has been revised downward by 74.68% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates 2024 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025
Revenue
YoY % growth
TBIO revenue by date.TBIO revenue by date.
11.043M
67.93%
27.435M
148.44%
27.509M
0.27%
9.384M
-65.89%
9.792M
4.35%
EBITDA
YoY % growth
TBIO ebitda by date.TBIO ebitda by date.
-34.466M
-122.43%
-44.814M
-30.02%
-32.83M
26.74%
-18.564M
43.45%
11.22M
160.44%
EBIT
YoY % growth
TBIO ebit by date.TBIO ebit by date.
-35.374M
-116.21%
-46.485M
-31.41%
-35.15M
24.38%
-26.214M
25.42%
1.02M
103.89%
Operating Margin
TBIO operating margin by date.TBIO operating margin by date.
-320.33%-169.44%-127.78%-279.35%10.42%
EPS
YoY % growth
TBIO eps by date.TBIO eps by date.
N/A
-3,798.67%
-1.65
94.78%
-11.45
-593.94%
-25.45
-122.26%
-19.27
24.29%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 24
EPS
Q2Q % growth
-2.91
29.78%
Revenue
Q2Q % growth
9.18M
31.58%
EBITDA
Q2Q % growth
-6.222M
-64.95%
EBIT
Q2Q % growth
-7.956M
-30.60%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TBIO Yearly Revenue VS EstimatesTBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
TBIO Yearly EPS VS EstimatesTBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

TELESIS BIO INC / TBIO Forecast FAQ

What do analysts expect the price target to be for TELESIS BIO INC (TBIO)?

7 analysts have analysed TBIO and the average price target is 4.08 USD. This implies a price increase of 26.32% is expected in the next year compared to the current price of 3.23.

When does TELESIS BIO INC (TBIO) report earnings?

TELESIS BIO INC (TBIO) will report earnings on 2024-11-11, after the market close.

Can you provide the consensus estimates for TELESIS BIO INC next earnings?

The consensus EPS estimate for the next earnings of TELESIS BIO INC (TBIO) is -2.91 USD and the consensus revenue estimate is 9.18M USD.